Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Inhibition of DPP-4 with Vildagliptin Improved Insulin Secretion in Response to Oral as well as Isoglycemic Intravenous Glucose without Numerically Changing the Incretin Effect in Patients with Type 2 Diabetes - Vardarli_2011_J.Clin.Endocrinol.Metab_96_945 |
| Author(s) : Vardarli I , Nauck MA , Kothe LD , Deacon CF , Holst JJ , Schweizer A , Foley JE |
| Ref : J Clinical Endocrinology Metab , 96 :945 , 2011 |
| Abstract : Vardarli_2011_J.Clin.Endocrinol.Metab_96_945 |
| ESTHER : Vardarli_2011_J.Clin.Endocrinol.Metab_96_945 |
| PubMedSearch : Vardarli_2011_J.Clin.Endocrinol.Metab_96_945 |
| PubMedID: 21239518 |
| Title : Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans - Ahren_2011_Diabetes.Obes.Metab_13_775 |
| Author(s) : Ahren B , Schweizer A , Dejager S , Villhauer EB , Dunning BE , Foley JE |
| Ref : Diabetes Obes Metab , 13 :775 , 2011 |
| Abstract : Ahren_2011_Diabetes.Obes.Metab_13_775 |
| ESTHER : Ahren_2011_Diabetes.Obes.Metab_13_775 |
| PubMedSearch : Ahren_2011_Diabetes.Obes.Metab_13_775 |
| PubMedID: 21507182 |
| Title : Role of vildagliptin in managing type 2 diabetes mellitus in the elderly - Halimi_2010_Curr.Med.Res.Opin_26_1647 |
| Author(s) : Halimi S , Raccah D , Schweizer A , Dejager S |
| Ref : Curr Med Res Opin , 26 :1647 , 2010 |
| Abstract : Halimi_2010_Curr.Med.Res.Opin_26_1647 |
| ESTHER : Halimi_2010_Curr.Med.Res.Opin_26_1647 |
| PubMedSearch : Halimi_2010_Curr.Med.Res.Opin_26_1647 |
| PubMedID: 20441397 |
| Title : An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials - Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495 |
| Author(s) : Ligueros-Saylan M , Foley JE , Schweizer A , Couturier A , Kothny W |
| Ref : Diabetes Obes Metab , 12 :495 , 2010 |
| Abstract : Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495 |
| ESTHER : Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495 |
| PubMedSearch : Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495 |
| PubMedID: 20518805 |
| Title : Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes - Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| Author(s) : Ahren B , Schweizer A , Dejager S , Dunning BE , Nilsson PM , Persson M , Foley JE |
| Ref : J Clinical Endocrinology Metab , 94 :1236 , 2009 |
| Abstract : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| ESTHER : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| PubMedSearch : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| PubMedID: 19174497 |
| Title : Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet - Halimi_2008_Vasc.Health.Risk.Manag_4_481 |
| Author(s) : Halimi S , Schweizer A , Minic B , Foley J , Dejager S |
| Ref : Vasc Health Risk Manag , 4 :481 , 2008 |
| Abstract : Halimi_2008_Vasc.Health.Risk.Manag_4_481 |
| ESTHER : Halimi_2008_Vasc.Health.Risk.Manag_4_481 |
| PubMedSearch : Halimi_2008_Vasc.Health.Risk.Manag_4_481 |
| PubMedID: 18827867 |
| Title : Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes - Fonseca_2007_Diabetologia_50_1148 |
| Author(s) : Fonseca V , Schweizer A , Albrecht D , Baron MA , Chang I , Dejager S |
| Ref : Diabetologia , 50 :1148 , 2007 |
| Abstract : Fonseca_2007_Diabetologia_50_1148 |
| ESTHER : Fonseca_2007_Diabetologia_50_1148 |
| PubMedSearch : Fonseca_2007_Diabetologia_50_1148 |
| PubMedID: 17387446 |
| Title : Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study - Garber_2007_Diabetes.Obes.Metab_9_166 |
| Author(s) : Garber AJ , Schweizer A , Baron MA , Rochotte E , Dejager S |
| Ref : Diabetes Obes Metab , 9 :166 , 2007 |
| Abstract : Garber_2007_Diabetes.Obes.Metab_9_166 |
| ESTHER : Garber_2007_Diabetes.Obes.Metab_9_166 |
| PubMedSearch : Garber_2007_Diabetes.Obes.Metab_9_166 |
| PubMedID: 17300592 |
| Title : The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion - El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| Author(s) : El-Ouaghlidi A , Rehring E , Holst JJ , Schweizer A , Foley J , Holmes D , Nauck MA |
| Ref : J Clinical Endocrinology Metab , 92 :4165 , 2007 |
| Abstract : El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| ESTHER : El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| PubMedSearch : El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| PubMedID: 17698900 |
| Title : Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year - Ahren_2005_Diabetes.Care_28_1936 |
| Author(s) : Ahren B , Pacini G , Foley JE , Schweizer A |
| Ref : Diabetes Care , 28 :1936 , 2005 |
| Abstract : Ahren_2005_Diabetes.Care_28_1936 |
| ESTHER : Ahren_2005_Diabetes.Care_28_1936 |
| PubMedSearch : Ahren_2005_Diabetes.Care_28_1936 |
| PubMedID: 16043735 |
| Title : Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes - Ahren_2004_Diabetes.Care_27_2874 |
| Author(s) : Ahren B , Gomis R , Standl E , Mills D , Schweizer A |
| Ref : Diabetes Care , 27 :2874 , 2004 |
| Abstract : Ahren_2004_Diabetes.Care_27_2874 |
| ESTHER : Ahren_2004_Diabetes.Care_27_2874 |
| PubMedSearch : Ahren_2004_Diabetes.Care_27_2874 |
| PubMedID: 15562200 |